These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1310 related items for PubMed ID: 32650743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y, Lin K, Liu L, Qian Y, Yang Y, Yuan S, Zhu P, Huang J, Liu F, Gu F, Fu S, Jiang B, Liu H, Pan Z, Lau WY, Zhou W.
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [Abstract] [Full Text] [Related]

  • 3. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z.
    Int J Med Sci; 2021 Mar; 18(1):187-198. PubMed ID: 33390787
    [Abstract] [Full Text] [Related]

  • 4. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C, Wang MD, Lu L, Wu H, Yu JJ, Zhang WG, Pawlik TM, Zhang YM, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Xing H, Li ZL, Lau WY, Wu MC, Shen F, Yang T.
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX.
    World J Gastroenterol; 2017 Nov 07; 23(41):7415-7424. PubMed ID: 29151695
    [Abstract] [Full Text] [Related]

  • 6. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M.
    Eur Radiol; 2018 Aug 07; 28(8):3522-3531. PubMed ID: 29536241
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
    Shen WF, Zhong W, Liu Q, Sui CJ, Huang YQ, Yang JM.
    World J Surg; 2011 Sep 07; 35(9):2083-91. PubMed ID: 21698503
    [Abstract] [Full Text] [Related]

  • 8. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
    Ke Q, Xiang F, Xiao C, Huang Q, Liu X, Zeng Y, Wang L, Liu J.
    BMC Cancer; 2021 Oct 18; 21(1):1117. PubMed ID: 34663242
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J, Wang Q, Lei Z, Wu D, Si A, Wang K, Wan X, Wang Y, Yan Z, Xia Y, Lau WY, Wu M, Shen F.
    Oncologist; 2015 Jun 18; 20(6):640-7. PubMed ID: 25956404
    [Abstract] [Full Text] [Related]

  • 10. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
    Liu S, Li H, Guo L, Zhang B, Zhou B, Zhang W, Zhou J, Fan J, Ye Q.
    Oncologist; 2019 Apr 18; 24(4):513-520. PubMed ID: 30552155
    [Abstract] [Full Text] [Related]

  • 11. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK, Choi GH, Lee HC, Shin YM, An J, Lee D, Shim JH, Kim KM, Lim YS, Chung YH, Lee YS.
    PLoS One; 2018 Apr 18; 13(6):e0198138. PubMed ID: 29879137
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH, Guo Z, Lu HF, Wang XB, Yang HJ, Yang FQ, Bao SY, Zhong JH, Li LQ, Yang RR, Xiang BD.
    World J Gastroenterol; 2015 Apr 21; 21(15):4627-34. PubMed ID: 25914472
    [Abstract] [Full Text] [Related]

  • 13. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L, Deng M, Ke Q, Lou J, Zheng S, Bi X, Wang J, Guo W, Li F, Wang J, Zheng Y, Li J, Cheng S, Zhou W, Zeng Y.
    Cancer Med; 2020 Apr 21; 9(8):2674-2685. PubMed ID: 32072774
    [Abstract] [Full Text] [Related]

  • 14. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.
    Liver Int; 2014 Jul 21; 34(6):953-60. PubMed ID: 24134199
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study.
    Lazuardi F, Valencia J, Zheng S.
    Scand J Gastroenterol; 2019 May 21; 54(5):617-622. PubMed ID: 31079496
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 17. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C, Liao Y, Qiu J, Yuan Y, Zhang Y, Li K, Zou R, Wang Y, Zuo D, He W, Zheng Y, Li B, Yuan Y.
    J Cancer Res Clin Oncol; 2020 Oct 02; 146(10):2669-2680. PubMed ID: 32449005
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.
    Chen MY, Juengpanich S, Hu JH, Topatana W, Cao JS, Tong CH, Lin J, Cai XJ.
    World J Gastroenterol; 2020 Mar 14; 26(10):1042-1055. PubMed ID: 32205995
    [Abstract] [Full Text] [Related]

  • 19. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
    Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K, Chai ZT, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ.
    Ann Surg Oncol; 2019 May 14; 26(5):1465-1473. PubMed ID: 30767178
    [Abstract] [Full Text] [Related]

  • 20. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G, Guo W, Wang H, Liu W, Lei L, Xie Q, Li X, Zou S, Wang P, Zhou H, Hu H.
    Ann Palliat Med; 2021 Apr 14; 10(4):3673-3683. PubMed ID: 33691434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.